Literature DB >> 678454

Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)--therapeutic problems.

E Folkers, J Tafelkruyer.   

Abstract

A patient with subcorneal pustular dermatosis with a fatal outcome is presented. Treatment with corticosteroids, vitamin E, dapsone, sulphapyridine and levamisole was ineffective. Only systemic treatment with retinoic acid and a new aromatic retinoic acid derivative (Ro 10-9359) produced a satisfactory clinical response, but a complete remission was not obtained.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 678454     DOI： 10.1111/j.1365-2133.1978.tb03588.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

Review 2.  Autoinflammatory pustular neutrophilic diseases.

Authors:  Haley B Naik; Edward W Cowen
Journal:  Dermatol Clin       Date:  2013-06-02       Impact factor: 3.478

3.  Subcorneal pustular dermatosis associated with rheumatoid arthritis and raised IgA: simultaneous remission of skin and joint involvements with dapsone treatment.

Authors:  H Roger; J P Thevenet; P Souteyrand; B Sauvezie
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

Review 4.  Why don't we use vitamin E in dermatology?

Authors:  K Pehr; R R Forsey
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

Review 5.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

Review 6.  Synthetic retinoids in dermatology.

Authors:  E H Heller; N J Shiffman
Journal:  Can Med Assoc J       Date:  1985-05-15       Impact factor: 8.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.